|
|
|
|
| LEADER |
04192nam a2200301 c 4500 |
| 001 |
22-15-qucosa2-709124 |
| 007 |
cr |
| 008 |
2020 eng |
| 037 |
|
|
|a urn:nbn:de:bsz:15-qucosa2-709124
|
| 041 |
|
|
|a eng
|
| 082 |
|
|
|a 610
|
| 100 |
|
|
|a Panchal, Omkar Vikram
|
| 245 |
|
|
|a Analysis of SATB1 in Head and Neck Squamous Cell Carcinoma
|b SATB1 in HNSCC
|
| 336 |
|
|
|b txt
|
| 338 |
|
|
|b nc
|
| 533 |
|
|
|a Online-Ausg.
|d 2020
|e Online-Ressource (Text)
|f Universitätsbibliothek Leipzig
|
| 502 |
|
|
|b Dissertation
|c Universität Leipzig
|d 2019
|
| 505 |
|
|
|a 156 pages
|
| 520 |
|
|
|a Squamous cell carcinoma of the head and neck region (HNSCC) is an aggressive malignancy with generally poor prognosis and high mortality. The Special AT-rich binding protein 1 (SATB1) is a genome organizer protein that participates in regulating gene expression by acting as a trans-acting element as well as by recruiting chromatin remodeling complexes and enzymes. SATB1 is often overexpressed in cancer, and its possible role in tumour progression has been explored in several types of cancers and also suggested in HNSCC. However, its influence on molecular and cellular processes in HNSCC has not been examined, and, using primary cell lines, provided the basis of this thesis. This is a comprehensive study of molecular and cellular processes being affected upon siRNA-mediated SATB1 knockdown in vitro and in vivo. 15 HNSCC primary cell lines were obtained from the University of Turku and screened for SATB1 mRNA levels. The comparison of SATB1 mRNA levels with location, lymph node metastasis, disease staging (TNM) or SATB2 mRNA levels revealed no association. Hence, for deeper analysis 7 primary cell lines were selected based on growth inhibitory effects upon transient SATB1 knockdown, rather than their initial SATB1 mRNA levels. Growth inhibition upon SATB1 depletion was shown in monolayer (viable cell quantitation and colony forming ability) as well as non-adherent (spheroid assay) culture conditions. In some cell lines, cell death induced by apoptosis or retardation of cell cycle progression was observed as well. Parallel to this, using the FLAVINO assay, colony forming abilities of tumour cells from patient biopsies obtained from the University Hospital of Leipzig (Department of Otorhinolaryngology, Head and Neck Surgery) were tested post SATB1 knockdown. For molecular analysis, effects of SATB1 knockdown on transcription rates of selected oncogenes were analyzed. Among EMT markers, N-cadherin and beta catenin levels were found reduced upon SATB1 knockdown. The transcription of HER3 and its ligands Heregulin α & β was attenuated in all the seven primary cell lines, irrespectively of the growth inhibitory effects of SATB1 knockdown. These results demonstrated the role of SATB1 in the process of EMT and in autocrine signalling. Effects of HER3 inhibition on transcription rates of SATB1 were tested as well. HER3 inhibition was achieved by Patritumab, a novel monoclonal antibody against HER3. While SATB1 transcription rates remained unchanged upon HER3 inhibition, growth inhibition assays (2D and 3D) revealed that the combined use of HER1 and HER3 inhibitory antibodies provides better tumour cell inhibition over the single treatment. Finally, antitumor effects of SATB1 knockdown were monitored in vivo in two xenograft models (UT-SCC-14 and UT-SCC-42B). Treatment of tumor xenograft-bearing mice with siRNAs formulated in polymeric nanoparticles revealed reduced tumour growth, based on the knockdown of SATB1 as demonstrated on the protein level. Taken together, in this work SATB1 knockdown is demonstrated to mediate growth inhibition, induction of apoptosis, cell cycle retardation, negative impact on EMT and autocrine signaling and in vivo anti-tumour effects, thus highlighting the relevance of SATB1 in HNSCC.
|
| 650 |
|
|
|a Satb1
|
| 650 |
|
|
|a Hnscc
|
| 650 |
|
|
|a Rnai
|
| 650 |
|
|
|a Molecular Oncology
|
| 650 |
|
|
|a Rna Drugs
|
| 655 |
|
|
|a Hochschulschrift
|2 gnd-content
|
| 856 |
4 |
0 |
|q text/html
|u https://nbn-resolving.org/urn:nbn:de:bsz:15-qucosa2-709124
|z Online-Zugriff
|
| 935 |
|
|
|c hs
|
| 980 |
|
|
|a 15-qucosa2-709124
|b 22
|c sid-22-col-qucosa
|
SOLR
| _version_ |
1797365362065408000 |
| author |
Panchal, Omkar Vikram |
| author_facet |
Panchal, Omkar Vikram |
| author_role |
|
| author_sort |
Panchal, Omkar Vikram |
| author_variant |
o v p ov ovp |
| building |
Library A |
| collection |
sid-22-col-qucosa |
| contents |
156 pages, Squamous cell carcinoma of the head and neck region (HNSCC) is an aggressive malignancy with generally poor prognosis and high mortality. The Special AT-rich binding protein 1 (SATB1) is a genome organizer protein that participates in regulating gene expression by acting as a trans-acting element as well as by recruiting chromatin remodeling complexes and enzymes. SATB1 is often overexpressed in cancer, and its possible role in tumour progression has been explored in several types of cancers and also suggested in HNSCC. However, its influence on molecular and cellular processes in HNSCC has not been examined, and, using primary cell lines, provided the basis of this thesis. This is a comprehensive study of molecular and cellular processes being affected upon siRNA-mediated SATB1 knockdown in vitro and in vivo. 15 HNSCC primary cell lines were obtained from the University of Turku and screened for SATB1 mRNA levels. The comparison of SATB1 mRNA levels with location, lymph node metastasis, disease staging (TNM) or SATB2 mRNA levels revealed no association. Hence, for deeper analysis 7 primary cell lines were selected based on growth inhibitory effects upon transient SATB1 knockdown, rather than their initial SATB1 mRNA levels. Growth inhibition upon SATB1 depletion was shown in monolayer (viable cell quantitation and colony forming ability) as well as non-adherent (spheroid assay) culture conditions. In some cell lines, cell death induced by apoptosis or retardation of cell cycle progression was observed as well. Parallel to this, using the FLAVINO assay, colony forming abilities of tumour cells from patient biopsies obtained from the University Hospital of Leipzig (Department of Otorhinolaryngology, Head and Neck Surgery) were tested post SATB1 knockdown. For molecular analysis, effects of SATB1 knockdown on transcription rates of selected oncogenes were analyzed. Among EMT markers, N-cadherin and beta catenin levels were found reduced upon SATB1 knockdown. The transcription of HER3 and its ligands Heregulin α & β was attenuated in all the seven primary cell lines, irrespectively of the growth inhibitory effects of SATB1 knockdown. These results demonstrated the role of SATB1 in the process of EMT and in autocrine signalling. Effects of HER3 inhibition on transcription rates of SATB1 were tested as well. HER3 inhibition was achieved by Patritumab, a novel monoclonal antibody against HER3. While SATB1 transcription rates remained unchanged upon HER3 inhibition, growth inhibition assays (2D and 3D) revealed that the combined use of HER1 and HER3 inhibitory antibodies provides better tumour cell inhibition over the single treatment. Finally, antitumor effects of SATB1 knockdown were monitored in vivo in two xenograft models (UT-SCC-14 and UT-SCC-42B). Treatment of tumor xenograft-bearing mice with siRNAs formulated in polymeric nanoparticles revealed reduced tumour growth, based on the knockdown of SATB1 as demonstrated on the protein level. Taken together, in this work SATB1 knockdown is demonstrated to mediate growth inhibition, induction of apoptosis, cell cycle retardation, negative impact on EMT and autocrine signaling and in vivo anti-tumour effects, thus highlighting the relevance of SATB1 in HNSCC. |
| dewey-full |
610 |
| dewey-hundreds |
600 - Technology (Applied sciences) |
| dewey-ones |
610 - Medicine and health |
| dewey-raw |
610 |
| dewey-search |
610 |
| dewey-sort |
3610 |
| dewey-tens |
610 - Medicine and health |
| facet_avail |
Online, Free |
| finc_class_facet |
Technik, Medizin |
| fincclass_txtF_mv |
medicine |
| format |
eBook, Thesis |
| format_access_txtF_mv |
Thesis |
| format_de14 |
Thesis, Book, E-Book |
| format_de15 |
Thesis, Book, E-Book |
| format_del152 |
Buch, Buch |
| format_detail_txtF_mv |
text-online-monograph-independent-thesis |
| format_dezi4 |
e-Book |
| format_finc |
Book, E-Book, Thesis |
| format_legacy |
Thesis, Book |
| format_legacy_nrw |
Thesis, Book, E-Book |
| format_nrw |
Thesis, Book, E-Book |
| format_strict_txtF_mv |
E-Thesis |
| genre |
Hochschulschrift gnd-content |
| genre_facet |
Hochschulschrift |
| geogr_code |
not assigned |
| geogr_code_person |
not assigned |
| id |
22-15-qucosa2-709124 |
| illustrated |
Not Illustrated |
| imprint |
Online-Ausg., 2020 |
| imprint_str_mv |
Online-Ausg.: 2020 |
| institution |
DE-105, DE-Gla1, DE-Brt1, DE-D161, DE-540, DE-Pl11, DE-Rs1, DE-Bn3, DE-Zi4, DE-Zwi2, DE-D117, DE-Mh31, DE-D275, DE-Ch1, DE-15, DE-D13, DE-L242, DE-L229, DE-L328 |
| is_hierarchy_id |
|
| is_hierarchy_title |
|
| language |
English |
| last_indexed |
2024-04-26T03:13:01.928Z |
| match_str |
panchal2020analysisofsatb1inheadandnecksquamouscellcarcinomasatb1inhnscc |
| mega_collection |
Qucosa |
| publishDateSort |
2020 |
| record_format |
marcfinc |
| record_id |
15-qucosa2-709124 |
| recordtype |
marcfinc |
| rvk_facet |
No subject assigned |
| source_id |
22 |
| spelling |
Panchal, Omkar Vikram, Analysis of SATB1 in Head and Neck Squamous Cell Carcinoma SATB1 in HNSCC, txt, nc, Online-Ausg. 2020 Online-Ressource (Text) Universitätsbibliothek Leipzig, Dissertation Universität Leipzig 2019, 156 pages, Squamous cell carcinoma of the head and neck region (HNSCC) is an aggressive malignancy with generally poor prognosis and high mortality. The Special AT-rich binding protein 1 (SATB1) is a genome organizer protein that participates in regulating gene expression by acting as a trans-acting element as well as by recruiting chromatin remodeling complexes and enzymes. SATB1 is often overexpressed in cancer, and its possible role in tumour progression has been explored in several types of cancers and also suggested in HNSCC. However, its influence on molecular and cellular processes in HNSCC has not been examined, and, using primary cell lines, provided the basis of this thesis. This is a comprehensive study of molecular and cellular processes being affected upon siRNA-mediated SATB1 knockdown in vitro and in vivo. 15 HNSCC primary cell lines were obtained from the University of Turku and screened for SATB1 mRNA levels. The comparison of SATB1 mRNA levels with location, lymph node metastasis, disease staging (TNM) or SATB2 mRNA levels revealed no association. Hence, for deeper analysis 7 primary cell lines were selected based on growth inhibitory effects upon transient SATB1 knockdown, rather than their initial SATB1 mRNA levels. Growth inhibition upon SATB1 depletion was shown in monolayer (viable cell quantitation and colony forming ability) as well as non-adherent (spheroid assay) culture conditions. In some cell lines, cell death induced by apoptosis or retardation of cell cycle progression was observed as well. Parallel to this, using the FLAVINO assay, colony forming abilities of tumour cells from patient biopsies obtained from the University Hospital of Leipzig (Department of Otorhinolaryngology, Head and Neck Surgery) were tested post SATB1 knockdown. For molecular analysis, effects of SATB1 knockdown on transcription rates of selected oncogenes were analyzed. Among EMT markers, N-cadherin and beta catenin levels were found reduced upon SATB1 knockdown. The transcription of HER3 and its ligands Heregulin α & β was attenuated in all the seven primary cell lines, irrespectively of the growth inhibitory effects of SATB1 knockdown. These results demonstrated the role of SATB1 in the process of EMT and in autocrine signalling. Effects of HER3 inhibition on transcription rates of SATB1 were tested as well. HER3 inhibition was achieved by Patritumab, a novel monoclonal antibody against HER3. While SATB1 transcription rates remained unchanged upon HER3 inhibition, growth inhibition assays (2D and 3D) revealed that the combined use of HER1 and HER3 inhibitory antibodies provides better tumour cell inhibition over the single treatment. Finally, antitumor effects of SATB1 knockdown were monitored in vivo in two xenograft models (UT-SCC-14 and UT-SCC-42B). Treatment of tumor xenograft-bearing mice with siRNAs formulated in polymeric nanoparticles revealed reduced tumour growth, based on the knockdown of SATB1 as demonstrated on the protein level. Taken together, in this work SATB1 knockdown is demonstrated to mediate growth inhibition, induction of apoptosis, cell cycle retardation, negative impact on EMT and autocrine signaling and in vivo anti-tumour effects, thus highlighting the relevance of SATB1 in HNSCC., Satb1, Hnscc, Rnai, Molecular Oncology, Rna Drugs, Hochschulschrift gnd-content, text/html https://nbn-resolving.org/urn:nbn:de:bsz:15-qucosa2-709124 Online-Zugriff |
| spellingShingle |
Panchal, Omkar Vikram, Analysis of SATB1 in Head and Neck Squamous Cell Carcinoma: SATB1 in HNSCC, 156 pages, Squamous cell carcinoma of the head and neck region (HNSCC) is an aggressive malignancy with generally poor prognosis and high mortality. The Special AT-rich binding protein 1 (SATB1) is a genome organizer protein that participates in regulating gene expression by acting as a trans-acting element as well as by recruiting chromatin remodeling complexes and enzymes. SATB1 is often overexpressed in cancer, and its possible role in tumour progression has been explored in several types of cancers and also suggested in HNSCC. However, its influence on molecular and cellular processes in HNSCC has not been examined, and, using primary cell lines, provided the basis of this thesis. This is a comprehensive study of molecular and cellular processes being affected upon siRNA-mediated SATB1 knockdown in vitro and in vivo. 15 HNSCC primary cell lines were obtained from the University of Turku and screened for SATB1 mRNA levels. The comparison of SATB1 mRNA levels with location, lymph node metastasis, disease staging (TNM) or SATB2 mRNA levels revealed no association. Hence, for deeper analysis 7 primary cell lines were selected based on growth inhibitory effects upon transient SATB1 knockdown, rather than their initial SATB1 mRNA levels. Growth inhibition upon SATB1 depletion was shown in monolayer (viable cell quantitation and colony forming ability) as well as non-adherent (spheroid assay) culture conditions. In some cell lines, cell death induced by apoptosis or retardation of cell cycle progression was observed as well. Parallel to this, using the FLAVINO assay, colony forming abilities of tumour cells from patient biopsies obtained from the University Hospital of Leipzig (Department of Otorhinolaryngology, Head and Neck Surgery) were tested post SATB1 knockdown. For molecular analysis, effects of SATB1 knockdown on transcription rates of selected oncogenes were analyzed. Among EMT markers, N-cadherin and beta catenin levels were found reduced upon SATB1 knockdown. The transcription of HER3 and its ligands Heregulin α & β was attenuated in all the seven primary cell lines, irrespectively of the growth inhibitory effects of SATB1 knockdown. These results demonstrated the role of SATB1 in the process of EMT and in autocrine signalling. Effects of HER3 inhibition on transcription rates of SATB1 were tested as well. HER3 inhibition was achieved by Patritumab, a novel monoclonal antibody against HER3. While SATB1 transcription rates remained unchanged upon HER3 inhibition, growth inhibition assays (2D and 3D) revealed that the combined use of HER1 and HER3 inhibitory antibodies provides better tumour cell inhibition over the single treatment. Finally, antitumor effects of SATB1 knockdown were monitored in vivo in two xenograft models (UT-SCC-14 and UT-SCC-42B). Treatment of tumor xenograft-bearing mice with siRNAs formulated in polymeric nanoparticles revealed reduced tumour growth, based on the knockdown of SATB1 as demonstrated on the protein level. Taken together, in this work SATB1 knockdown is demonstrated to mediate growth inhibition, induction of apoptosis, cell cycle retardation, negative impact on EMT and autocrine signaling and in vivo anti-tumour effects, thus highlighting the relevance of SATB1 in HNSCC., Satb1, Hnscc, Rnai, Molecular Oncology, Rna Drugs, Hochschulschrift |
| title |
Analysis of SATB1 in Head and Neck Squamous Cell Carcinoma: SATB1 in HNSCC |
| title_auth |
Analysis of SATB1 in Head and Neck Squamous Cell Carcinoma SATB1 in HNSCC |
| title_full |
Analysis of SATB1 in Head and Neck Squamous Cell Carcinoma SATB1 in HNSCC |
| title_fullStr |
Analysis of SATB1 in Head and Neck Squamous Cell Carcinoma SATB1 in HNSCC |
| title_full_unstemmed |
Analysis of SATB1 in Head and Neck Squamous Cell Carcinoma SATB1 in HNSCC |
| title_short |
Analysis of SATB1 in Head and Neck Squamous Cell Carcinoma |
| title_sort |
analysis of satb1 in head and neck squamous cell carcinoma satb1 in hnscc |
| title_sub |
SATB1 in HNSCC |
| title_unstemmed |
Analysis of SATB1 in Head and Neck Squamous Cell Carcinoma: SATB1 in HNSCC |
| topic |
Satb1, Hnscc, Rnai, Molecular Oncology, Rna Drugs, Hochschulschrift |
| topic_facet |
Satb1, Hnscc, Rnai, Molecular Oncology, Rna Drugs, Hochschulschrift |
| url |
https://nbn-resolving.org/urn:nbn:de:bsz:15-qucosa2-709124 |
| urn |
urn:nbn:de:bsz:15-qucosa2-709124 |
| work_keys_str_mv |
AT panchalomkarvikram analysisofsatb1inheadandnecksquamouscellcarcinomasatb1inhnscc |
